Fulvestrant (F)/Goserelin (G) vs Anastrozole (A)/G vs G for Premenopausal Women
Status: UNKNOWN
Study type: INTERVENTIONAL
Conditions: Metastatic Breast Cancer|Estrogen Receptor Positive Tumor|Breast Cancer Nos Premenopausal
Interventions: DRUG: Fulvestrant plus Goserelin|DRUG: Anastrozole plus Goserelin|DRUG: Goserelin
Sponsor: Samsung Medical Center
Collaborators: Asan Medical Center|Seoul National University Hospital|Severance Hospital|Ulsan University Hospital|Kosin University Gospel Hospital|Korea University Guro Hospital|Korea University Anam Hospital